- Market Capitalization, $K 3,458,284
- Shares Outstanding, K 360,990
- Annual Sales, $ 8,434 M
- Annual Income, $ -948,000 K
- 60-Month Beta 1.62
- Price/Sales 0.40
- Price/Cash Flow 1.04
- Price/Book N/A
|Period||Period Low||Period High||Performance|
| || |
-10.69 (-52.02%)since 04/26/22
| || |
-14.49 (-59.51%)since 02/25/22
| || |
-22.10 (-69.15%)since 05/26/21
ASX, CNMD, and BHC have been added to the Zacks Rank #5 (Strong Sell) List on May 19, 2022.
The global pharmaceutical market might cross the $1.5 trillion threshold by 2023, while national health spending is expected to increase over the coming years. And growing investments in breakthrough developments...
The company shocked investors with its loss, although today may also be a major capitulation for the stock.
Bausch (BHC) misses on earnings and sales in the first quarter due to incremental macro pressures and a challenging supply chain environment.
Despite the prevailing bearish investor sentiment, the healthcare industry is expected to continue growing amid an increase in global chronic diseases, rapid medical advancements, and an aging population....
Let's look at the five biotech/drug companies that are slated to release quarterly results on May 10.
BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -5.31% and 80.59%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The market selloff caused by the difficult macroeconomic and geopolitical issues has led many quality stocks to now trade below their intrinsic values. Agilent Technologies (A), United Therapeutics (UTHR),...
Bausch Health (BHC) closed the most recent trading day at $18.85, moving -0.84% from the previous trading session.
The impact of COVID-19 and continued pricing pressure on the Zacks Medical-Generic Drugs industry remains. New product launches may provide some respite for BHC, AMPH and SLGL.
|Bausch Health Companies Inc|
|Jpmorgan Betabuilders Canada ETF|
|Xt MSCI All World Ex US Hedged Equity ETF|
|Principal Intl Adaptive Multi-Factor ETF|
|Xt MSCI Kokusai Equity ETF|
|Schwab Fundamental Intl Large CO ETF|